Dr. Hansel is a pulmonary and critical care medicine physician. She is an expert in the diagnosis and treatment of obstructive airway diseases, including asthma and chronic obstructive pulmonary disease (COPD), and care of patients in the Medical ICU. Dr. Hansel is rated as an Elite provider by MediFind in the treatment of Emphysema. Her top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Asthma, Bronchitis, and Endoscopy.

Dr. Wise is a pulmonary, critical care physician. He is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. He is a consultant for patients with scleroderma and interstitial lung disease. He has expertise in pulmonary physiology and lung function testing. Dr. Wise’s research focus is the conduct of multi-center clinical trials in airway diseases and related translational research. Dr. Wise is the co-director of the Pulmonary T32 Multi-disciplinary Training Program in Pulmonary Disease. Dr. Wise is rated as a Distinguished provider by MediFind in the treatment of Emphysema. His top areas of expertise are Systemic Sclerosis (SSc), Interstitial Lung Disease, Acute Interstitial Pneumonia, and Sarcoidosis.

Neil Waravdekar is an Intensive Care Medicine provider in Frederick, Maryland. Dr. Waravdekar is rated as a Distinguished provider by MediFind in the treatment of Emphysema. His top areas of expertise are Emphysema, Bullae, Lung Nodules, and Lung Metastases.

Anthony Perella is an Intensive Care Medicine provider in Pocomoke City, Maryland. Dr. Perella is rated as a Distinguished provider by MediFind in the treatment of Emphysema. His top areas of expertise are Emphysema, Bullae, Lung Metastases, and Chronic Obstructive Pulmonary Disease (COPD).

Fernando Deleon is an Intensive Care Medicine provider in Chestertown, Maryland. Dr. Deleon is rated as a Distinguished provider by MediFind in the treatment of Emphysema. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Emphysema, and Bullae.

David Oliver is an Intensive Care Medicine provider in Easton, Maryland. Dr. Oliver is rated as a Distinguished provider by MediFind in the treatment of Emphysema. His top areas of expertise are Bronchiolitis Obliterans, Industrial Bronchitis, Lung Metastases, and Bronchiectasis.

David Nizza is a Radiologist in Salisbury, Maryland. Dr. Nizza is rated as a Distinguished provider by MediFind in the treatment of Emphysema. His top areas of expertise are Gallbladder Disease, Bronchogenic Cyst, CAPOS Syndrome, Pleurisy, and Bone Marrow Aspiration.

Dr. Putcha is a pulmonary and critical care physician. She is an expert in the diagnosis and treatment of lung disease (specifically obstructive lung diseases such as COPD and asthma), and in the care of critically ill patients in the Medical ICU. She is a member of the Lung Research Conference Planning Committee and provides teaching to medical students and residents at Johns Hopkins. Dr. Putcha is rated as an Advanced provider by MediFind in the treatment of Emphysema. Her top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Cerebral Hypoxia, and Asthma.

Dr. Erin D. Michos is a Professor of Medicine within the Division of Cardiology at Johns Hopkins School of Medicine, with joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Women's Cardiovascular Health and the Associate Director of Preventive Cardiology within the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. Dr. Michos is an internationally known expert in Preventive Cardiology and Women’s Health, having authored >700 publications and 11 book chapters. Her research involves (1) Women’s Cardiovascular Health; (2) Lipids and Lipid management; (3) Cardio-Kidney-Metabolic and Obesity disease management (4) Coronary artery calcium, inflammation and biomarkers of cardiovascular risk. She is the co-Editor-in-Chief for the American Journal of Preventive Cardiology. She is Co-Director of the IMPACT Center (Improving Participation Among Diverse Populations in Cardiovascular Clinical Trials) at Johns Hopkins, funded by the American Heart Association (AHA). She is a co-investigator in several NIH-funded studies including the Multi-Ethnic Study of Atherosclerosis and Atherosclerosis Risk in Communities cohorts. She has served as the Training Director for four AHA Strategic Focused Research Networks. She has mentored over 60 individuals and the recipient of 2 mentoring awards. Additionally, she was the recipient of the Nanette Wegner Award for Women’s Health Medical Leadership by the Women Heart Organization and the Donna Vogel Women’s Health Champion Award by Johns Hopkins University. Dr. Michos completed medical school at Northwestern University, Internal Medicine residency and Cardiology fellowship at the Johns Hopkins Hospital, and a Masters of Health Science degree at the Johns Hopkins Bloomberg School of Public Health. Dr. Michos is rated as an Advanced provider by MediFind in the treatment of Emphysema. Her top areas of expertise are Atherosclerosis, Vitamin D Deficiency, Heart Failure, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Dr. Neptune is a pulmonary, critical care physician with expertise in genetic disorders of the matrix with pulmonary manifestations. She is also skilled in the management of patients with advanced obstructive lung disease, especially emphysema. Dr. Neptune has extensive expertise in the diagnosis and management of the pulmonary complications of Marfan Syndrome, Loeys-Dietz Syndrome, vascular Ehlers Danlos Syndrome and other matrix disorders and serves on the Professional Advisory Board of the Marfan Foundation. She is also an expert on tobacco dependence and is the Vice-Chair of the Tobacco Action Committee of the American Thoracic Society. Dr. Neptune earned her M.D. from Harvard Medical School. She completed her residency and performed a fellowship in pulmonary and critical care at the University of California, San Francisco. She also performed a fellowship in genetics at Johns Hopkins. Her research interests include therapeutic strategies in Marfan syndrome; mechanisms and prevention of progression of COPD; and hepatocyte growth factor signaling in airspace homeostasis. Dr. Neptune is committed to creating a diverse research community and clinical workforce. She is involved in multiple diversity initiatives at Johns Hopkins and the American Thoracic Society. She is also involved in increasing awareness of tobacco dependence and the needed regulatory policies. Dr. Neptune serves on the Compliance Compensation Subcommittee for the Department of Medicine. Dr. Neptune is rated as an Advanced provider by MediFind in the treatment of Emphysema. Her top areas of expertise are Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome), Acute Interstitial Pneumonia, Interstitial Lung Disease, and Emphysema.

Dr. Howard Steiner is an instructor of medicine at the Johns Hopkins School of Medicine. He has been practicing pulmonary and sleep consultative medicine since 1989. In his role as a diagnostician, he guides the evaluation and management of respiratory problems including infectious, malignant, allergic, autoimmune, and sleep-related disorders. He has been part-time faculty in the Johns Hopkins Pulmonary Division since 1991, is a Fellow in the American College of Chest Physicians, and mentors medical students, residents, and pulmonary fellows training at the Johns Hopkins Hospital. Contact for Research Inquiries 10755 Falls Road Pavilion I, Suite 200 Lutherville, MD 21093 Phone: (410) 583-7124 Selected Publications Lwebuga-Mukasa JS, Steiner H. Monoclonal antibody to rat lung Maclura Pomifera agglutinin (MPA) lectin binding glycoprotein localizes apically on rat and human type II pneumocytes and Clara cells. J Cell Biol 107:71a, 1989. Roberts PJ, McBean GJ, Steiner H, Kohler C, Schwarcz R. Lesioning Effects of Ibotenate in the immature rat brain and protection by 2-amino-7 phosphonoheptanoic acid. Soc Neurosci Abst 9:261, 1983. Steiner H, Ingbar DI. Mechanisms of lung injury and repair. In: Matthay RA, Matthay MA, Wiedemann HP eds. Annual Review of Pulmonary and Critical Care Medicine. Hanley & Belfus (Philadelphia, 1989), pp 205-223. Steiner H, Lwebuga-Mukasa JS. A549 cells display distinct functional and morphologic properties depending on their culture substratum. J Cell Biol 107:71a, 1989. Steiner H, Lwebuga-Mukasa JS. A549 cells produce a factor which is Mitogenic for human lung fibroblasts. Amer Rev Resp Dis 139:A492 1989. Steiner H, McBean GJ, Kohler C, Roberts PJ, Schwarcz R. Ibotenate Induced neuronal degeneration in immature rat brain. Brain Research 307:117-124, 1984. Dr. Steiner is rated as an Advanced provider by MediFind in the treatment of Emphysema. His top areas of expertise are Bronchiectasis, Obstructive Sleep Apnea, Lung Metastases, and Interstitial Lung Disease.

Dr. McCormack is a pulmonary, critical care physician and Associate Director of the Pulmonary & Critical Care Medicine Division. She is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. She has expertise in pulmonary physiology. She serves as the Medical Director of the Johns Hopkins University Pulmonary Function Laboratory and as the Chair of the American Thoracic Society Pulmonary Function Test Committee. She earned her M.D. from Jefferson Medical College of Thomas Jefferson University and her M.H.S. from the Bloomberg School of Public Health. She completed her residency at Thomas Jefferson University Hospital and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. She was the recipient of the Frederick L. Brancati Excellence in Mentoring Award. She plays an active role in mentoring fellows and junior faculty in the Pulmonary & Critical Care Medicine Division. Dr. Mccormack is rated as an Advanced provider by MediFind in the treatment of Emphysema. Her top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Asthma, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant.

Dr. Fawzy is a pulmonary and critical care physician. He is an expert in the diagnosis and treatment of lung disease with a particular focus on asthma and COPD (emphysema and chronic bronchitis) and in the care of critically ill patients in the Medical ICU. Dr. Fawzy earned his M.D. from Stony Brook University. He completed his residency at Boston University Medical Center and fellowship in pulmonary and critical care medicine at Johns Hopkins University. Dr. Fawzy joined the Johns Hopkins faculty in 2020, and is supported by the NIH to conduct clinical and translational research investigating the role of platelet phenotypes in COPD. Dr. Fawzy is rated as an Advanced provider by MediFind in the treatment of Emphysema. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Cerebral Hypoxia, Emphysema, and Bronchitis.

Paul M. Hassoun, M.D., is professor of medicine at the Johns Hopkins University School of Medicine and the director of the pulmonary hypertension program at Johns Hopkins Hospital. He received his medical degree from the Faculté de Médecine Lariboisière-Saint Louis at the University of Paris, France, completed an internship and residency at Brigham and Women’s Hospital and a fellowship in Pulmonary and Critical Care Medicine at Massachusetts General Hospital, both at Harvard Medical School. He was on faculty in the pulmonary division at New England Medical Center/Tufts University School of Medicine (Tufts-NEMC) in Boston, MA, until 2002 when he joined the division of pulmonary and critical care medicine at Johns Hopkins University. Dr. Hassoun has served or currently serves on numerous American Thoracic Society (ATS) assemblies and committees, including the Pulmonary Circulation Long Range Planning Committee, the Pulmonary Circulation Program Committee (for which he served as chair for 2008-2009), the ATS Scientific Advisory Council, Pulmonary Circulation Leadership Committee, and the American College of Chest Physicians Vascular Steering Committee. He served as the ATS Pulmonary Circulation chair (2011-2012) and on the ATS Publications Policy Committee. He was recently elected president of the Pulmonary Vascular Research Institute (PVRI; 2018-2019). Dr. Hassoun has held numerous editorial activities including serving on the editorial board of the American Journal of Respiratory and Critical Medicine (2010 to present), CHEST (2006-2015) and the European Respiratory Review (2008-2015). He currently serves as associate editor of the European Respiratory Journal (2013-present) and has served as associate editor for the Journal of Clinical Investigation (2017-2022). Dr. Hassoun is rated as an Advanced provider by MediFind in the treatment of Emphysema. His top areas of expertise are Pulmonary Hypertension, Systemic Sclerosis (SSc), Pulmonary Veno-Occlusive Disease, Cerebral Hypoxia, and Lung Transplant.

Cheng Zhou is an Intensive Care Medicine provider in Elkton, Maryland. Dr. Zhou has been practicing medicine for over 10 years and is rated as an Advanced provider by MediFind in the treatment of Emphysema. Her top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Eosinophilic Asthma, and Emphysema.

David Holden, M.D., practices pulmonary medicine at Johns Hopkins Community Physicians Pulmonology & Sleep Medicine. He received his medical degree from the University Of Cincinnati College Of Medicine, and also completed his residency in internal medicine at the Cleveland Clinic. Dr. Holden is rated as an Advanced provider by MediFind in the treatment of Emphysema. His top areas of expertise are Acute Interstitial Pneumonia, Lung Metastases, Pneumonia, and Interstitial Lung Disease.

Aparna Balasubramanian is a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Balasubramanian is rated as an Advanced provider by MediFind in the treatment of Emphysema. Her top areas of expertise are Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Veno-Occlusive Disease, Emphysema, and Lung Transplant.

George Reeder is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Salisbury, Maryland. Dr. Reeder is rated as a Distinguished provider by MediFind in the treatment of Emphysema. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Acute Interstitial Pneumonia, and Interstitial Lung Disease. Dr. Reeder is currently accepting new patients.

Anish Desai is an Intensive Care Medicine provider in Frederick, Maryland. Dr. Desai is rated as an Advanced provider by MediFind in the treatment of Emphysema. His top areas of expertise are Emphysema, Bullae, Obstructive Sleep Apnea, and Lung Metastases.

Keith Goulet is an Intensive Care Medicine provider in Annapolis, Maryland. Dr. Goulet is rated as an Advanced provider by MediFind in the treatment of Emphysema. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Bullae, and Cerebral Hypoxia.